I checked FDA dot Gov and the Marianne trial page was updated yesterday. The estimated final completion date is Feb 2016?
another interesting fact, the Dec $13 calls are bid at .30. To be in the money IMGN would need to move 30%+ in 24 days???
another interesting fact, the Dec options are moving, but the outer months are not moving nearly as much in price but 3000 Jan calls traded...???
yes, but that's not new today is it? Something new happened today, I noticed huge options trades, over 8000 total contracts have traded, that's waaaaaay more then the usual 100 or so. The Dec 9 put activity is the only thing that concerns me, it says news is coming, but we don't know it it's going to be a + or a -. That's why I speculated on the TDM1 trial info. I thought .40 was a steal for selling the Dec 9 with 24 days remaining and price over $10, then it went to .45 - .65. Stock volume is not high. Very strange!
Clearly something significant is happening. calls and puts are very active and highly prices. Far more calls (over 7000) than puts (about 1000) have traded.
wow, huge new positions, something big is up. Could be BO, could be something negative like a secondary to pay for their buy in on the BT drug. The puts are less active, but prices are also up. I sold some Dec puts, pricing was just too good, which is usually a bad sign...
true if you believe that BB's are not the owners of the majority of the short position and are more long than short, but somewhat hedged (as must prudent investors tend to do with such a huge gain). There's a huge OI in the Jan calls. If BB's planned to start exiting in Jan through the calls and now the filing timing has changed, they might roll those out (not that a widely expected filing is a big event). Jan should be a very interesting month.
you are correct, nothing works in AML is what I should have typed. The naked antibody looks fantastic. The only problem for IMGN is their royalties for this are very low. One of the analysts that was negative overall on IMGN estimated the naked drug to be a $1BB+ seller.
Interesting, the SI reporting date is right about the time the price started the latest decline. Of course, the weak sales numbers are not helping, but I would bet SI has increased since the latest report.
this sounds very positive. IMGN has been very quiet about their options with Biotest, the costs, the financial deal, when they need to decide, can they sub-license, or partner their interests. Maybe they need to concentrate their finances on this product and 289 and try to partner the other internal products ASAP and get all of their associated costs down. Nothing works in ALL, so I have low expectations for the newest compound. If it does work, there is no competition.
He's not a doctor, or an analyst but he tries to play one on the internet.
couuld be a rolling of options from the prior month, but volume strong. I sold a few higher price options, but left most shares unrestricted in case someone wants to acquire EXAS.